Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CFAP61 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | SEP15 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | C10orf95 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | LEPR | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | DNLZ | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | MAP3K9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | GID8 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | CLMP | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | ADGRV1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | HHAT | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |